Impact of Hybrid Coronary Revascularization on Antiplatelet Therapy

CompletedOBSERVATIONAL
Enrollment

40

Participants

Timeline

Start Date

October 31, 2010

Primary Completion Date

April 30, 2013

Study Completion Date

April 30, 2013

Conditions
Coronary Artery Disease
Interventions
PROCEDURE

Hybrid coronary revascularization

Hybrid coronary revascularization with standard double antiplatelet therapy

Trial Locations (1)

8200

Aarhus University Hospital, Aarhus

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Danish Heart Foundation

OTHER

collaborator

Aase and Ejnar Danielsens Foundation

OTHER

lead

Aarhus University Hospital Skejby

OTHER

NCT02293928 - Impact of Hybrid Coronary Revascularization on Antiplatelet Therapy | Biotech Hunter | Biotech Hunter